GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia
This study is ongoing, but not recruiting participants.
Human Genome Sciences Inc.
Information provided by (Responsible Party):
First received: April 28, 2011
Last updated: February 25, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||March 2019|
|Primary Completion Date:||September 2015 (Final data collection date for primary outcome measure)|